FemTherapeutics
PrivateLast Round
Seed
Jun 2, 2023
Est. Valuation
$8M
Total Funding Raised
$1.97M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FemTherapeutics operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Seed round in June 2023.
FemTherapeutics is a medical technology company that develops personalized, non-invasive gynecological prosthetics and pelvic health solutions using artificial intelligence and 3D printing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, 3D Printing, Medical AI, Personalization
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FemTherapeutics Comparables
Compare FemTherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cosm Medical | 91% | |
| Reia | 81% | |
| ConTIPI Medical | 78% |
For institutional investors. Book with your work email.
FemTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 2, 2023 | ||||
| Angel | Nov 3, 2022 | ||||
| Grant | Sep 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FemTherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Seed |
| The51 | Seed |
| SheBoot | Seed, Angel |
| Capital Angel Network | Angel |
| National Research Council Canada | Grant |
| 2048 Ventures | Seed |
| The M51 Founder Lab | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 40% MoM.
- Jun 2, 2023
$1.85M raised led by 2048 Ventures.
For institutional investors. Book with your work email.
FemTherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FemTherapeutics's valuation, stock price, and market status.
Is FemTherapeutics a public or private company?
FemTherapeutics is a private company.
What is the current stock price of FemTherapeutics?
FemTherapeutics is a private company, so its shares have no public market price. Caplight tracks FemTherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FemTherapeutics worth (valuation)?
FemTherapeutics's valuation is estimated at $8.0M based on funding round data.
Can I buy FemTherapeutics stock?
FemTherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FemTherapeutics's last funding round?
FemTherapeutics's most recent funding round was Seed on June 2, 2023.
Who are the main investors in FemTherapeutics?
Key investors in FemTherapeutics include 2048 Ventures.
Will FemTherapeutics IPO soon?
No public IPO plans have been announced for FemTherapeutics.
How can I track FemTherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in FemTherapeutics's shares on secondary markets.